Collectively, these findings imply that pharmacological VC not only activates tumor cGAS through cytoplasmic dsDNA leakage, but also increases tumor cGAS expression via epigenetic modifications by Tet2-dependent DNA demethylation. Here, CGAS is linked to neoplasm.